Exploring prognostic factors in patients achieving PCR after neoadjuvant therapy for triple-negative breast cancer: A retrospective study based on SEER data

被引：0
|
作者：
Wenjie, L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Breast Surg, Sch Med, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
38P
引用
收藏
页码：S1480 / S1480
页数：1
相关论文
共 50 条
  • [21] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Hiroko Masuda
    Norikazu Masuda
    Yoshinori Kodama
    Masami Ogawa
    Michiko Karita
    Jun Yamamura
    Kazunori Tsukuda
    Hiroyoshi Doihara
    Shinichiro Miyoshi
    Masayuki Mano
    Shoji Nakamori
    Toshimasa Tsujinaka
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 911 - 917
  • [22] Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Hess, Kenneth
    Santiago, Lumarie
    Lane, Deanna L.
    Thompson, Alastair M.
    Moulder, Stacy L.
    Huang, Monica L.
    Arribas, Elsa M.
    Rauch, Gaiane M.
    Leung, Jessica W. T.
    Symmans, W. Fraser
    Valero, Vicente
    Ravenberg, Elizabeth E.
    White, Jason B.
    Yang, Wei Tse
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 130
  • [23] The Prognostic Significance of the Fibrinogen-to-Albumin Ratio in Patients With Triple-Negative Breast Cancer: A Retrospective Study
    Yang, Qinheng
    Liang, Dong
    Yu, Yang
    Lv, Feng
    FRONTIERS IN SURGERY, 2022, 9
  • [24] Risk factors and prognostic factors of brain metastasis of triple-negative breast cancer: A single-center retrospective study
    He, Chunyu
    Mamuti, Guliqihere
    Mushajiang, Munire
    Maimatiniyazi, Simayili
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (04)
  • [25] Efficacy of neoadjuvant systemic carboplatin therapy in triple-negative breast cancer
    Thomssen, Christoph
    Schuler, Kathleen
    Bauer, Marcus
    Reinhardt, Kristin
    Strauss, Hans-Gerorg
    Vetter, Martina
    CANCER RESEARCH, 2022, 82 (04)
  • [26] Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
    Yam, Clinton
    Yen, Er-Yen
    Chang, Jeffrey T.
    Bassett, Roland L., Jr.
    Alatrash, Gheath
    Garber, Haven
    Huo, Lei
    Yang, Fei
    Philips, Anne, V
    Ding, Qing-Qing
    Lim, Bora
    Ueno, Naoto T.
    Kannan, Kasthuri
    Sun, Xiangjie
    Sun, Baohua
    Cuentas, Edwin Roger Parra
    Symmans, William Fraser
    White, Jason B.
    Ravenberg, Elizabeth
    Seth, Sahil
    Guerriero, Jennifer L.
    Rauch, Gaiane M.
    Damodaran, Senthil
    Litton, Jennifer K.
    Wargo, Jennifer A.
    Hortobagyi, Gabriel N.
    Futreal, Andrew
    Wistuba, Ignacio I.
    Sun, Ryan
    Moulder, Stacy L.
    Mittendorf, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5365 - 5375
  • [27] Evolving Evidence for the Optimization of Neoadjuvant Therapy in Triple-Negative Breast Cancer
    Silva, Diogo
    Mesquita, Alexandra
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2022, 16
  • [28] Extent of Breast Surgery After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Benson, John R.
    Dumitru, Dorin
    JAMA SURGERY, 2020, 155 (08) : 784 - 785
  • [29] Novel prognostic markers for patients with triple-negative breast cancer
    Zhou, Ling
    Li, Ke
    Luo, Yanli
    Tian, Ling
    Wang, Min
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (10) : 2180 - 2187
  • [30] The prognostic impact of age in patients with triple-negative breast cancer
    Liedtke, Cornelia
    Hess, K. R.
    Karn, T.
    Rody, A.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (02) : 591 - 599
12345